Call for papers - Pancreatitis and pancreatic cancer

Guest Editors

Rupjyoti Talukdar, MD, Asian Institute of Gastroenterology Hospitals, India
Ishaan Vohra, MD, University of Illinois College of Medicine, USA

Submission Status: Open | Submission Deadline: 21 March 2025

BMC Gastroenterology is calling for submissions to our new Collection Pancreatitis and pancreatic cancer. Pancreatitis, characterized by inflammation of the pancreas, poses substantial challenges in diagnosis, management, and understanding its underlying mechanisms. From acute to chronic forms, pancreatitis not only impairs the quality of life but also predisposes individuals to the development of pancreatic cancer, for which there are still limited therapeutic options available. Thus, revealing the pathophysiological pathways and identifying novel therapeutic targets is imperative in addressing this multifaceted disease spectrum. We invite submissions on various topics, including molecular pathways, imaging modalities, autoimmune and gallstone pancreatitis management, pancreatic cancer biomarkers, microbiota and pancreatic diseases, and therapeutic approaches for pancreatic insufficiency and alcohol-induced pancreatitis.

New Content Item This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

Submit to Collection

Meet the Guest Editors

Back to top

Rupjyoti Talukdar, MD, Asian Institute of Gastroenterology Hospitals, India

Rupjyoti Talukdar completed his undergraduate and postgraduate medical education at Gauhati Medical College in Guwahati, Assam, India. Following this, he trained in gastroenterology as a senior resident in New Delhi. He then migrated to the University of Minnesota, Minneapolis, to pursue postdoctoral training in bench research in pancreatology, with a special focus on the molecular mechanisms of acute pancreatitis. After completing this training, he joined the Mayo Clinic in Rochester, USA, for an advanced GI-Pancreatology Fellowship. Upon completion of the fellowship, he returned to India and joined the Asian Institute of Gastroenterology (AIG). At AIG, he developed and maintained his basic research labs and the pancreas research group with the aid of research grants from the Wellcome DBT India Alliance, DBT India, and Science and Research Board (SERB). His current research interests are early molecular events of acute pancreatitis, pain mechanisms and management in chronic pancreatitis, and the impact of gut microbial dysbiosis on the exocrine and endocrine changes in pancreatitis.

Ishaan Vohra, MD, University of Illinois College of Medicine, USA

Ishaan Vohra is ABIM-certified in Internal Medicine and Gastroenterology, excelling in clinical research and patient care with a specialization in gastrointestinal pathologies. His expertise includes conducting evidence-based research, resulting in over 50 articles and 120 conference posters. Notably, he received 2,432 citations with an H-index of 19 by June 2024. As a member of the STOP-COVID investigators, he contributed to pivotal studies during the pandemic. His impactful publications, including NIH-funded projects, address diverse topics such as acute pancreatitis and cannabinoid use disorders. He serves as a reviewer for high-impact journals and has contributed to developing clinical tools like the Cook County Score for esophageal varices risk assessment, which is widely used in research.

About the Collection

BMC Gastroenterology is calling for submissions to our new Collection on Pancreatitis and pancreatic cancer. Pancreatitis, characterized by inflammation of the pancreas, poses substantial challenges in diagnosis, management, and understanding its underlying mechanisms. From acute to chronic forms, pancreatitis not only impairs the quality of life but also predisposes individuals to the development of pancreatic cancer, which remains one of the biggest adversaries in oncology. Thus, revealing the pathophysiological pathways and identifying novel therapeutic targets is imperative in addressing this multifaceted disease spectrum.

Research in this field has already yielded notable advances, such as the identification of key genetic mutations driving pancreatic cancer and the development of targeted therapies like PARP inhibitors. Furthermore, collaborative efforts have elucidated the role of inflammatory pathways in pancreatitis, paving the way for anti-inflammatory therapies. Looking ahead, further insights into the molecular mechanisms and microenvironmental dynamics of these diseases hold promise for the development of more effective precision medicine approaches, immunotherapies, and early detection methods.

This Collection invites contributions across a spectrum of topics, including but not limited to:

Molecular pathways in pancreatitis
The role of inflammation in pancreatic cancer
Imaging modalities for pancreatic lesions
Diagnosis and management of autoimmune pancreatitis
Current trends in gallstone pancreatitis
Advances and challenges of pancreatic cancer biomarkers
Clinical considerations for ascites in advanced pancreatic cancer
Novel therapeutic approaches to pancreatic insufficiency
Epidemiology and prevention of alcohol-induced pancreatitis
Surgical interventions for chronic pancreatitis
The microbiota and pancreatic diseases
Pain in chronic pancreatitis with emphasis on neural mechanisms

This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Pancreatitis and pancreatic cancer" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.